Chemical In Car Seats May Increase Cancer Risks For Long Commuters: Study

Having a long commute to work or school may increase an individual’s exposure to cancer-causing flame retardants, according to the findings of a new study.

Exposure to flame retardant chemicals after only one week of commuting could increase the risk of cancer and other serious side effects, according to University of California, Riverside, and Duke University researchers. The findings were published in the March issue of the journal Environment International.

Researchers studied exposure to flame retardants used in vehicle parts. They focused on tris(1,3-dichloro-2-propyl) phosphate (TDCIPP), a common flame retardant and known carcinogen used to manufacture vehicle seat foam.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Nearly 100 participants who commuted in Southern California were asked to wear silicone wristbands to monitor organophosphates esters (OPE) and semi-volatile organic compound (SVOC) exposure for five continuous days. They were also asked to  complete daily surveys about the amount of time spent commuting.

The findings indicate that a long commute increases a person’s exposure to TDCIPP. Less than one week of commuting resulted in elevated exposure to the flame retardant, according to the researchers.

Recent studies have shown many humans have exposure to high levels of toxic flame retardants which are harmful to the human body. Other studies have linked exposure to these chemicals to increased risk of preterm birth and negative effects to thyroid function.

Flame retardants are often used to treat children’s car seats, play equipment, furniture, and the foam in gymnastic equipment.

OPEs, including flame retardants can migrate out of consumer products. The residue is often found in car dust samples around the world.

Considering large portions of the human population live in large cities and surrounding areas, and spend one or more hours in their car everyday commuting to and from work and other activities, researchers warn this could lead to long-term exposure to TDCIPP and eventually serious health side effects.

“Overall, our findings raise concerns about the potential for chronic TDCIPP exposure within vehicles and other forms of transportation, particularly within densely populated and traffic-congested areas such as Southern California,” the researchers determined.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

AFFF Ulcerative Colitis Lawsuit Filed Over Contaminated Water in Colorado Springs
AFFF Ulcerative Colitis Lawsuit Filed Over Contaminated Water in Colorado Springs (Posted today)

Lawsuit blames PFAS manufacturers for failing to prevent water contamination by their chemicals, or warn municipalities and the public about the potential risks of ulcerative colitis and other diseases as a result of exposure.

Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria
Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria (Posted yesterday)

Hundreds of currently pending Bard PowerPort lawsuits over infections, fractures and migration injuries were consolidated into a multidistrict litigation (MDL), but now even more claims present similar allegations that the implantable port catheter system has dangerous design defects that were not adequately disclosed by the manufacturer.

Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters
Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters (Posted yesterday)

A recent report suggests that Johnson & Johnson is offering an additional $1.1 billion to settle talcum powder lawsuits, as part of a proposed $9 billion deal that would resolve all ovarian cancer claims as part of a third bankruptcy filing by the manufacturer.